Chronic Airway Infection/Inflammation Induces a Ca 2+ i -dependent Hyperinflammatory Response in Human Cystic Fibrosis Airway Epithelia by Ribeiro, Carla M.Pedrosa et al.
Chronic Airway Infection/Inflammation Induces a Ca2i-dependent
Hyperinflammatory Response in Human Cystic Fibrosis
Airway Epithelia*
Received for publication, September 15, 2004, and in revised form, March 2, 2005
Published, JBC Papers in Press, March 3, 2005, DOI 10.1074/jbc.M410618200
Carla M. Pedrosa Ribeiro‡, Anthony M. Paradiso, Ute Schwab§, Juan Perez-Vilar, Lisa Jones,
Wanda O’Neal, and Richard C. Boucher
From the Cystic Fibrosis Center and Department of Medicine, University of North Carolina,
Chapel Hill, North Carolina 27599
Hyperinflammatory responses to infection have been
postulated as a component of cystic fibrosis (CF) lung dis-
ease. Studies have linked intracellular calcium (Ca2i) mo-
bilization with inflammatory responses in several systems.
We have reported that the pro-inflammatory mediator bra-
dykinin (BK) promotes larger Ca2i signals in CF compared
with normal bronchial epithelia, a response that reflects
endoplasmic reticulum (ER)/Ca2 store expansion induced
by chronic luminal airway infection/inflammation. The
present study investigated whether CF airway epithelia
were hyperinflammatory and, if so, whether the hyperin-
flammatory CF phenotype was linked to larger Ca2 stores
in the ER. We found that F508 CF bronchial epithelia were
hyperinflammatory as defined by an increased basal and
mucosal BK-induced interleukin (IL)-8 secretion. However,
the CF hyperinflammation expressed in short-term (6–11-
day-old) primary cultures of F508 bronchial epithelia was
lost in long-term (30–40-day-old) primary cultures of F508
bronchial epithelia, indicating this response was independ-
ent of mutant cystic fibrosis transmembrane conductance
regulator. Exposure of 30–40-day-old cultures of normal
airway epithelia to supernatant from mucopurulent mate-
rial (SMM) from CF airways reproduced the increased ba-
sal and mucosal BK-stimulated IL-8 secretion of short-term
CF cultures. The BK-triggered increased IL-8 secretion in
SMM-treated cultures was mediated by an increased Ca2i
mobilization consequent to an ER expansion associated
with increases in protein synthesis (total, cytokines, and
antimicrobial factors). The increased ER-dependent, Ca2i-
mediated hyperinflammatory epithelial response may rep-
resent a general beneficial airway epithelial adaptation to
transient luminal infection. However, in CF airways, the
Ca2i-mediated hyperinflammation may be ineffective in
promoting the eradication of infection in thickened mucus
and, consequently, may have adverse effects in the lung.
In CF1 airway epithelia, the absence of the cystic fibrosis
transmembrane conductance regulator (CFTR)-mediated Cl
secretion, coupled with increased Na absorption, results in a
reduced periciliary liquid layer depth (1), adherence of thick-
ened mucus to airway surfaces, and persistent airway infec-
tions (2–5). It remains controversial whether the inflammatory
response of CF airways to infection is intrinsically excessive
and, thus, accelerates lung disease. As evidence for excessive
inflammation, cytokines are elevated in sputa from CF com-
pared with disease control (asthmatic) patients (6), and bron-
choalveolar lavage studies have revealed higher levels of cyto-
kines and inflammatory cells referenced to bacterial number or
endotoxin levels in CF versus non-CF patients with acute lung
infection (4, 7).
Many studies have addressed the magnitude of airway epi-
thelial inflammatory responses to infection in CF by focusing
on the regulation of cytokine production by the transcription
factor nuclear factor (NF)-B (8, 9), including its regulation by
toll receptors (10). In addition, intracellular calcium (Ca2i)
signals resulting from heterotrimeric G protein-coupled recep-
tor (GPCR) activation by inflammatory mediators or infectious
agents also modulate NF-B activation by a Ca2i-dependent
mechanism (11–17). For example, the pro-inflammatory medi-
ator bradykinin (BK) triggers Ca2i mobilization (18) and in-
duces interleukin (IL)-8 secretion in non-CF and CF human
airway epithelia (19). Furthermore, the CF pathogens Pseudo-
monas aeruginosa and Staphylococcus aureus promote IL-8
secretion by a Ca2i mobilization-dependent mechanism in air-
way epithelial cells (20).
We have shown that apical purinoceptor (P2Y2 receptors) or
BK receptor activation induces larger Ca2i signals in CF com-
pared with normal human airway epithelia (21, 22), and this
exaggerated Ca2i response results from luminal infection/in-
flammation-induced up-regulation of the apically confined en-
doplasmic reticulum (ER) Ca2 stores (22). The possibility that
the amplified ER-derived Ca2i responses provide a clue to the
pathogenesis of CF hyperinflammation was raised by studies of
other diseases. For example, in a model for Gaucher disease,
hippocampal cells expressed a greater glutamate-dependent
ER Ca2 release, consequent to an increased ER size, which
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appeared linked to the neuronal toxicity characteristic of this
disease (23). Moreover, presenillin mutations in Alzheimer dis-
ease have been associated with increases in ER size, Ca2
stores, and cytokine production (24, 25). In the case of CF, the
possible relationships among ER expansion, enhanced cytokine
release, and CF airways inflammation are unknown.
In the present study, we tested the hypothesis that CF
airway epithelia express a hyperinflammatory phenotype re-
sulting from luminal infection/inflammation-induced up-reg-
ulation of ER Ca2 stores. Accordingly, we investigated the
following: 1) whether CF airway epithelia have increased
IL-8 release in response to the inflammatory peptide BK as
compared with normal airway epithelia; 2) whether this re-
sponse is an epithelial adaptation to luminal infection/in-
flammation or depends on mutant F508 CFTR; and 3)
whether greater ER-derived Ca2i responses contribute to
the increased cytokine release in an in vitro model for CF
airway epithelial inflammation.
MATERIALS AND METHODS
Cell Culture and Freshly Excised Tissue—Tissues and cells were ob-
tained under the auspices of protocols approved by the Institutional Com-
mittee on the Protection of the Rights of Human Subjects. Excess tissues
from human donor lungs and excised recipient lungs were obtained at the
time of lung transplantation from main stem or lobar bronchi. Tissues
were either fixed in 4% paraformaldehyde and embedded in paraffin or
used for cell isolation. Bronchial epithelial cells were provided by the
University of North Carolina Cystic Fibrosis Center Tissue Core. Normal
and CF (F508 homozygous) cells were harvested and cultured as previ-
ously described (22). Cultures were maintained at an air-liquid surface
interface, and polarized primary cultures were studied at 6–11 days
(short-term cultures) or at 30–40 days (long-term cultures).
IL-8 Secretion—For basal, apical BK-stimulated, UTP-stimulated, or
SMM from CF airways (see “Studies with Infectious/Inflammatory Ma-
terial from CF Airways”)-stimulated IL-8 secretion, the serosal media
were collected at selected times from short-term or long-term cultures of
normal and CF bronchial epithelia. IL-8 was measured by enzyme-
linked immunosorbent assay (R&D Systems) in duplicate.
Studies with Infectious/Inflammatory Material from CF Airways—
Mucopurulent material was harvested from the airway lumens of ex-
cised human CF lungs infected with P. aeruginosa and S. aureus at the
time of transplant and provided by the Tissue Core of the University of
North Carolina Cystic Fibrosis Center as recently described (22). This
material was centrifuged at 100,000 rpm (60 min, 4 °C), and the super-
natant was filtered through a 0.2-m filter and frozen at 80 °C.
Preliminary studies revealed that treatment of airway epithelia with
SMM from individual CF lungs infected with P. aeruginosa and
S. aureus induced epithelial hyperinflammation. Because of the small
volume of SMM per patient and the large number of experiments,
SMMs from nine CF lungs (five males and four females; age, 17–48
years; four F508 homozygous and five unknown genotypes) were
pooled to assure homogeneous stimulus throughout experiments.
PBS or SMM (40 l) was applied to the mucosal surfaces of normal
or CF bronchial epithelia, and the following protocols were utilized.
First, to compare the inflammatory response of normal versus CF
cultures to luminal infectious/inflammatory stimuli, cultures were
treated with PBS or SMM, and a time course was performed for IL-8
secretion. Second, to test whether SMM-treated cultures were sensi-
tized to a subsequent inflammatory stimulus, cultures were treated
with PBS or SMM for 24–36 h, and the serosal media were replaced
by fresh media, followed by mucosal BK (5 M) or UTP (100 M) and
serial measurements of IL-8 secretion. Third, to address the role of
Ca2i mobilization on SMM-potentiated BK-induced IL-8 secretion,
cultures were treated with PBS or SMM for 36 h, followed by removal
of the medium and BAPTA/acetoxymethyl ester loading as previously
described (21). BK (5 M) was subsequently mucosally added to
cultures in a nominally Ca2-free solution (21), and Ca2i mobiliza-
tion was assessed as previously reported (22); in parallel experi-
ments, IL-8 release into the serosal compartment was measured 2 h
later. Fourth, to assess the effect of SMM on IL-8, IL-6, and IL-1
secretion, cultures were treated with PBS or SMM for up to 120 h,
and the serosal media were collected and replaced every 24 h for
cytokine measurements. Fifth, to address the effect of SMM on total
protein synthesis, the incorporation of 35S-labeled amino acids into pro-
teins synthesized by cultures metabolically labeled with [35S]cysteine/
methionine (26) was measured after 48 h of PBS or SMM treatment.
Immunostaining of ER Protein Synthetic Markers—The immuno-
staining of ER chaperone proteins in cultures of bronchial airway epi-
thelia or deparaffinized native bronchial epithelial sections was per-
formed according to a modification of our previous method (27).
Cultures or epithelial sections were incubated with the primary anti-
bodies, a rabbit (1:100 dilution) and a mouse (5 g/ml; Stressgen)
antibody, for BIP and PDI, respectively, followed by a fluorescein-
labeled goat anti-rabbit antibody and a Texas Red-labeled goat anti-
mouse antibody (1:200 dilution; Jackson Immunoresearch Laborato-
ries). As controls, the primary antibodies were omitted. The
fluorescent signals were studied by laser confocal microscopy (Leica
model TCS 4D; PL APO 63x/1.20 mm water lens) in the XZ or XY
scanning mode.
The quantification of the fluorescence intensity of labeled BIP and PDI
was performed according to a previous method (22). Multiple scans were
obtained from each sample, and regions of interest were designated in the
apical domains with the MetaMorph software. The same acquisition pa-
rameters (e.g. laser power, contrast, brightness, and pinhole value) for
each channel were employed to acquire the images from paired normal
bronchial epithelial cultures treated in different ways or native normal
versus CF bronchial epithelia in experiments performed on the same day.
The fluorescence intensity values from the regions of interest were aver-
aged from paired cultures and native bronchial epithelial tissues.
XBP-1 mRNA Splicing—The assessment of XBP-1 mRNA splicing
was an adaptation of a previous method (28, 29). Long-term bronchial
epithelial cultures were mucosally treated with 40 l of PBS or SMM for
48 h or 1 M thapsigargin (TG) for 24 h, followed by three washes with
PBS. 1 ml of RNAlaterTM (Qiagen) was added to the mucosal and
serosal surfaces, and cultures were frozen at 20 °C. Total RNA was
isolated using RNeasy (Qiagen), and 200 ng of RNA was reverse tran-
scribed by SuperScript II RNase H reverse transcriptase (Invitrogen)
using 250 ng of random primers. PCR primers were designed to amplify
a 270-bp region of XBP-1 (sequence number NM_005080). The PCR
product spans a 26-bp intron that, when spliced by IRE1, results in a
translated XBP-1 mRNA that codes for an active transcription factor.
The unspliced PCR product contains a PstI site, which is destroyed after
splicing. The PCR protocol was 1 cycle at 94 °C for 7 min; 35 cycles of
94 °C for 30 s, 53 °C for 30 s, and 72 °C for 30 s; followed by 1 cycle of
72 °C for 7 min and holding at 4 °C. The PCR products were run on a 2%
agarose gel, column-purified using a QIAquick PCR Purification Kit
(Qiagen), and digested with PstI to visualize the 270-bp product
(spliced product) and the two 140-bp products (unspliced product).
To quantify the amount of unspliced product, a Southern blot was
performed using the PstI-digested PCR product from PBS- and SMM-
treated cultures. DNA was run on a 2% agarose gel, capillary blot
transferred, cross-linked to the membrane, and probed (Megaprime
DNA Labeling Kit; Amersham Biosciences) with the 270-bp PCR
product from PBS-treated samples. Data were quantified with a
Storm phosphorimaging system.
Quantitation of BIP mRNA—Quantitative real-time PCR analysis
was used to evaluate changes in BIP mRNA from PBS- and SMM-
treated cultures utilizing the LightCycler (Roche Applied Science).
RNA was isolated according to standard RNA isolation procedures
involving phenol/choloroform extraction and purification/DNase
treatment using the Qiagen RNeasy purification kit. cDNA was gen-
erated from RNA samples (200 ng) using SuperScript II reverse
transcriptase. PCR amplification utilized the following primer se-
quences: 5 forward, TCCTATGTCGCCTTCACTCC; and 3 reverse,
TTTCCCAATAACCTCAGC.
Primers were initially tested for specificity by PCR and then by
melting curve analysis in the LightCycler instrument. A standard curve
was run utilizing a positive control cDNA to determine PCR reaction
efficiency. PBS- or SMM-treated samples were run in duplicate, and
cross-points were calculated using the LightCycler internal software.
As a control gene, glyceraldehyde-3-phosphate dehydrogenase was also
run in duplicate on each of the samples. Ratios of gene expression were
calculated as previously reported (30).
Statistics—Data represent the mean  S.E. from at least three
experiments from three individual donors and were analyzed by un-
paired t test or two-way analysis of variance. Statistical significance
was defined as p  0.05.
RESULTS
Short-term Primary Cultures of CF Airway Epithelia Exhibit
Increased Basal and BK-stimulated IL-8 Secretion—To inves-
tigate whether CF airway epithelia exhibit hyperinflammation,
ER Ca2 Stores and CF Airway Epithelial Inflammation 17799
we first compared the basal IL-8 secretion in 6–11-day-old
normal versus F508 homozygous CF primary bronchial epi-
thelial cultures. Fig. 1A illustrates that the baseline IL-8 se-
cretion was increased in short-term CF compared with normal
cultures. The effect of the pro-inflammatory agonist BK on IL-8
secretion was measured in parallel 6–11-day-old primary cul-
tures of normal and F508 homozygous CF bronchial epithelia.
Mucosal treatment with a maximal dose of BK (5 M) (18)
promoted greater IL-8 secretion in CF compared with normal
cultures (Fig. 1B). These data demonstrate that short-term
primary cultures of CF bronchial airway epithelia express a
hyperinflammatory phenotype.
Is the CF Hyperinflammatory Phenotype the Result of an
Intrinsic F508 CFTR Defect or an Acquired Epithelial Re-
sponse to Chronic Airway Infection/Inflammation?—To ad-
dress this issue, IL-8 secretion under basal and BK-stimulated
conditions was studied in long-term normal versus F508 ho-
mozygous CF primary bronchial epithelial cultures. Fig. 1C
demonstrates that the increased baseline IL-8 secretion in
short-term CF cultures compared with normal cultures (Fig.
1A) was lost after 30–40 days in culture. Furthermore, 30–40-
day-old CF cultures responded in the same manner to 5 M
mucosal BK-dependent IL-8 secretion as 30–40-day-old nor-
mal cultures (Fig. 1D). These data strongly suggest that the
hyperinflammatory state observed in short-term CF cultures
does not represent a defect intrinsic to the F508 CFTR geno-
type but, rather, is a response to the persistent infectious/
inflammatory milieu found in CF airways in vivo that wanes
with prolonged periods in the absence of the stimulus.
Can the CF Hyperinflammatory Phenotype Be Transferred to
Normal Airway Epithelia by Mucosal Exposure to CF Airway
Mucopurulent Material?—To test more directly for the role of
persistent infection and inflammation on hyperinflammatory re-
sponsiveness, we prepared a SMM from CF airway lumens, ex-
posed the lumens of airway epithelial cultures to it for prolonged
periods, and measured basal and BK-induced IL-8 release.
SMM-dependent IL-8 secretion was first investigated in
long-term 30–40-day-old primary cultures of normal and CF
bronchial epithelia acutely exposed to mucosal SMM for up to
6 h. Fig. 2A illustrates that the acute SMM treatment triggered
IL-8 secretion, but this response was similar in long-term nor-
mal and CF cultures for each interval.
We next assessed whether prolonged SMM pretreatment (36
h) conferred a “CF-like hyperinflammatory phenotype,” i.e. an
increased IL-8 secretory response to mucosal BK, in normal
airway epithelia and whether this response was different in
long-term cultures of CF epithelia. SMM-pretreated 30–40-
day-old normal epithelia exhibited an increased IL-8 secretion
FIG. 1. Short-term primary cultures
of CF bronchial airway epithelia ex-
hibit increased basal and BK-stimu-
lated IL-8 secretion, but their hyper-
inflammatory phenotype reverts
with time in the prolonged absence
of luminal infection/inflammation,
independently of defective F508
CFTR. A, time course for baseline IL-8
secretion in short-term (6–11-day-old)
cultures of normal and CF epithelia. B,
time course for mucosal BK (5 M)-stim-
ulated IL-8 secretion in 6–11-day-old cul-
tures of normal and CF epithelia. C, time
course for baseline IL-8 secretion in long-
term (30–40-day-old) cultures of normal
and CF epithelia. D, time course for mu-
cosal BK (5 M)-stimulated IL-8 secretion
in 30–40-day-old cultures of normal and
CF epithelia. White and black bars corre-
spond to normal and F508 CF epithelia,
respectively. Data are expressed as
mean  S.E.; n  3–4. *, p  0.05, CF
versus normal cultures.
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to BK (Fig. 2B) compared with 30–40-day-old normal epithelia
exposed to BK in the absence of SMM pretreatment (Fig. 1D).
Moreover, an increased BK-dependent IL-8 secretion was in-
duced in 30–40-day-old CF cultures pretreated for 36 h with
SMM (Fig. 2B), as compared with non-SMM treated cultures
(Fig. 1D). Notably, the IL-8 response of SMM-pretreated CF
cultures in the absence (Fig. 2A) or presence (Fig. 2B) of mu-
cosal BK was similar to that of normal cultures. Thus, these
data again argue against an intrinsic hyperinflammatory de-
fect associated with the F508 genotype but suggest that
chronic infection/inflammation (SMM) itself can induce the
hyperinflammatory phenotype.
Can the CF-like Hyperinflammatory Phenotype, e.g., the Am-
plified BK-dependent IL-8 Secretion in SMM-pretreated Nor-
mal Cultures, Be Reproduced with the Activation of Another
Receptor Coupled to Ca2i Mobilization?—Like BK receptors,
P2Y2 receptors are coupled to Ca
2
i mobilization (22). There-
fore, we investigated whether activation of this class of recep-
tors with UTP stimulated IL-8 secretion in airway epithelia
and, if so, whether SMM potentiated this response. Following a
24-h PBS pretreatment, 100 M mucosal UTP induced a modest
increase in IL-8 secretion in 30–40-day-old normal bronchial
epithelia compared with vehicle-treated cultures (Fig. 3). In
contrast, cultures pretreated with SMM secreted much higher
levels of IL-8 in response to 100 M mucosal UTP compared
with PBS-treated cultures (Fig. 3). These data suggest that the
increased IL-8 secretion triggered by apical activation of BK
receptors in SMM-pretreated cultures (Fig. 2B) may be a gen-
eral finding associated with the activation of GPCRs that trig-
ger increased Ca2i mobilization in chronically infected/in-
flamed airway epithelia (22).
Is SMM-potentiated BK-dependent IL-8 Secretion Dependent
on SMM-induced Expansion of the Releasable ER Ca2
Stores?—To address the role of Ca2i signals on the amplified
SMM-induced BK-dependent inflammatory response, we in-
vestigated BK-induced Ca2i mobilization in 30–40-day-old
normal bronchial airway epithelial cultures treated with PBS
versus SMM for 36 h. Mucosal BK (5 M) elicited Ca2i mobi-
lization in both PBS- and SMM-treated cultures, but the BK-
dependent Ca2i signal was amplified in SMM-treated epithe-
lia (Fig. 4, A and B, respectively). The compiled data for
BK-dependent 340/380 Fura-2 fluorescence (peak  baseline
values, an index of ER Ca2 store capacity in airway epithelia)
(22) illustrate that SMM pretreatment increased the ER Ca2
stores that can be mobilized following apical BK receptor acti-
vation (Fig. 4E). Utilizing a protocol previously shown to effec-
tively buffer Ca2i signals in airway epithelia (21), the Ca
2
i-
mobilizing effect of BK was completely blocked in BAPTA-
loaded PBS- or SMM-pretreated cultures (Fig. 4, C and D).
We next tested the effect of Ca2i clamping on BK-dependent
IL-8 secretion in epithelia treated with PBS versus SMM for
24 h. Fig. 5 illustrates that BAPTA was ineffective in blocking
BK-dependent IL-8 secretion in PBS-treated cultures. In con-
trast, the “hyperinflammatory” component of BK-dependent
IL-8 secretion in SMM-treated cultures was inhibited by
BAPTA. These data suggest that BK induces IL-8 secretion by
FIG. 3. Prolonged mucosal exposure of long-term primary cul-
tures of normal bronchial airway epithelia to the Ca2i-mobiliz-
ing agent UTP promotes IL-8 secretion, and this response is
potentiated by SMM pretreatment. 30–40-day-old primary cultures
of normal bronchial airway epithelia were mucosally exposed for 24 h to
PBS or SMM, followed by apical addition of vehicle or 100 M UTP, and
assessment of IL-8 secretion 6 h later. Data are expressed as mean 
S.E.; n  3. *, p  0.05, UTP- versus vehicle-treated cultures; , p 
0.05, SMM- versus PBS-treated cultures; #, p  0.05, UTP  SMM-
versus UTP  PBS-treated cultures.
FIG. 2. Long-term primary cultures of normal and CF epithelia respond in the same manner to luminal infectious/inflammatory
stimuli-induced IL-8 secretion. A, time course for IL-8 secretion following acute mucosal exposure of long-term (30–40-day-old) cultures of
normal and CF epithelia to SMM from CF airways. SMM also induces IL-8 secretion in short-term cultures (data not shown). B, time course for
mucosal BK (5 M)-stimulated IL-8 secretion in 30–40-day-old cultures of normal and CF epithelia pretreated for 36 h with mucosal SMM. The
y axis scales are the same as those from Fig. 1. White and black bars correspond to normal and F508 CF epithelia, respectively. Data are expressed
as mean  S.E.; n  3.
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Ca2i-independent and -dependent mechanisms. We speculate
that the absence of an effect of Ca2i buffering on BK-induced
IL-8 secretory responses in PBS-treated cultures reflects the
fact that the small BK-induced Ca2i signals in cells with
normal ER Ca2 stores did not reach the critical threshold
necessary to induce the Ca2i-mediated component of IL-8
secretion (Fig. 4A). In contrast, the larger BK-dependent Ca2i
signals resulting from the up-regulation of ER Ca2 stores by
SMM (Fig. 4B) were sufficient to produce a significant Ca2i-
dependent activation of signal transduction pathway(s) in-
volved in amplified IL-8 secretion.
To further investigate the Ca2i-independent component of
BK-induced IL-8 secretion in normal airway epithelia, cultures
were pretreated for 24 h with the ER Ca2-ATPase inhibitor
TG to deplete the ER Ca2 stores (31). As shown in Fig. 5, the
IL-8 response to BK in cultures whose ER Ca2 stores were
depleted with TG was the same as that seen in PBS-treated
cultures. Furthermore, BAPTA had no additional effect on
BK-dependent IL-8 secretion in TG-treated cultures (Fig. 5).
Collectively, these data suggest that apical BK receptor ac-
tivation triggers a Ca2i-independent component of IL-8 secre-
tion in PBS-, SMM-, and TG-pretreated cultures (indexed as
BAPTA-insensitive secretion) and a Ca2i-dependent, BAPTA-
sensitive component that requires SMM-dependent up-regula-
tion of ER Ca2 stores (Figs. 4 and 5).
Does SMM Induce Increased Protein Synthesis That Is
Linked to ER Expansion and Increased Ca2 Stores?—We have
recently shown that mucosal treatment of 30–40-day-old pri-
mary cultures of normal bronchial epithelia with SMM from CF
airways induces expansion of the apical ER compartment and
increases its Ca2 stores (22). ER expansion can be triggered by
conditions that increase protein synthesis, e.g. cellular differ-
entiation, antibody production, or infection (32–39). Thus, we
tested whether SMM produced an increase in protein synthesis
directly by measuring cytokine and total protein synthesis
rates in the absence and presence of SMM. SMM induced IL-8
secretion that was sustained for 120 h compared with PBS-
treated cultures (Fig. 6A). As a control, treatment of long-term
normal cultures with supernatant from luminal material iso-
lated from the lungs of two normal subjects elicited an IL-8
secretion that was only slightly higher than that triggered by
PBS (data not shown). SMM-treated long-term normal cultures
also exhibited increased secretion of IL-1 and IL-6, compared
with PBS-treated cultures (Fig. 6, B and C, respectively). More-
over, the mRNA levels of the antimicrobial -defensin2 were
increased by 6-fold in SMM-treated cultures compared with
PBS-treated cultures (data not shown).
The increased secretion of cytokines was a component of a
larger increase in total protein synthesis. Treatment of 30–40-
day-old normal airway epithelia with SMM for 48 h increased
total protein synthesis by 50% compared with PBS-treated
cultures (Fig. 6D). Together, these observations suggest that
SMM-increased cytokine secretion and antimicrobial factors are
components of a general increase in cellular protein synthesis
associated with expansion of the ER and ER Ca2 stores (22).
Is SMM-increased Synthesis of Inflammatory Mediators As-
sociated with Increased Expression of ER Proteins Involved in
Protein Synthesis?—Increases in cellular protein synthetic
rates are detected in the ER by sensors that trigger the expres-
sion of proteins that facilitate the folding requirements of
newly synthesized normal proteins (35–38). In mammalian
cells, increased protein synthesis is detected by two ER stress
FIG. 4. Prolonged mucosal exposure of long-term primary cultures of normal bronchial airway epithelia to SMM increases apical
BK-sensitive ER Ca2 stores. A and B, representative Ca2i tracings depicting the effect of 5 M apical BK-mobilized Ca
2
i in Fura-2-loaded
30–40-day-old primary cultures of normal bronchial airway epithelia mucosally exposed for 36 h to PBS or SMM, respectively. C and D,
representative Ca2i tracings from 30–40-day-old primary cultures of normal bronchial airway epithelia mucosally exposed for 36 h to PBS or
SMM, respectively, illustrating that the effect of 5 M apical BK-mobilized Ca2i is abolished by Ca
2
i buffering with BAPTA. E, compiled data for
apical BK-mobilized Ca2i (340/380 signal from Fura-2) from PBS- and SMM-pretreated cultures in the absence or presence of Ca
2
i chelation
with BAPTA. Data are expressed as mean  S.E.; n  3–4. *, p  0.05, SMM- versus PBS-treated cultures in the absence of BAPTA.
FIG. 5. Prolonged mucosal exposure of long-term primary cul-
tures of normal bronchial airway epithelia to SMM reproduces
a CF-like BK-dependent amplified IL-8 secretion that is medi-
ated by Ca2i mobilization. 30–40-day-old primary cultures of nor-
mal bronchial airway epithelia were mucosally exposed to PBS, SMM,
or TG (1 M) for 24 h, followed by vehicle or BAPTA addition in
nominally Ca2 free buffer as described under “Materials and Meth-
ods.” Cultures were subsequently exposed to 5 M mucosal BK, and IL-8
secretion was assessed 2 h later. Data are expressed as mean  S.E.;
n  3 for all groups. *, p  0.05, SMM- versus PBS-treated cultures in
the absence of BAPTA.
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sensors, IRE1 (40, 41) and the activating transcription factor 6
(ATF6) (35, 38, 42). For example, with increased protein syn-
thesis, the lumenal ER chaperone BIP leaves a BIPIRE1 com-
plex (43, 44) to facilitate the folding of the newly synthesized
proteins. Then, IRE1 dimerizes, trans-autophosphorylates, and
activates its C-terminal endoribonuclease (36, 38). This activity
splices the leucine zipper transcription factor XBP-1 mRNA via
removal of a 26-nucleotide intron and induces a frameshift of
the mRNA transcript (28, 29). The resulting XBP-1 mRNA is
efficiently translated into a potent transcription factor that
up-regulates genes such as those encoding ER chaperones in-
volved in protein folding, e.g. BIP and PDI (37, 45). ATF6, on
the other hand, undergoes proteolysis upon activation to pro-
duce a basic leucine zipper transcription factor that is respon-
sible for inducing transcription of ER chaperones as well as
XBP-1 itself (46).
We tested whether increases in protein synthesis induced by
SMM treatment of 30–40-day-old normal bronchial epithelia
triggered XBP-1 mRNA splicing. Fig. 7A shows the effect of
48-h mucosal SMM versus PBS treatment on XBP-1 mRNA
splicing in four different cultures. SMM induced an 2.5-fold
increase of spliced XBP-1 mRNA over PBS (Fig. 7B). 6- or 24-h
SMM treatment also induced increases of XBP-1 mRNA splic-
ing as compared with PBS-treated cultures (data not shown).
Total unspliced XBP-1 mRNA was not increased after SMM
treatment (data not shown), suggesting that ATF6 activation-
dependent transcriptional regulation of XBP-1 was not trig-
gered by infection/inflammation. In addition, treatment of 30–
40-day-old normal bronchial epithelia with SMM increased BIP
mRNA (Fig. 7C) and BIP protein (Fig. 7, D and E) levels. These
results suggest that SMM-induced splicing of XBP-1 mRNA is
associated with increases in the expression of the ER chaper-
one BIP.
To investigate whether persistent luminal infection/inflam-
mation was also associated with markers of increased ER pro-
tein synthesis in native CF airway epithelia, we studied the
expression of the ER chaperones BIP and PDI in CF bronchial
epithelia freshly isolated from chronically infected airways.
The distribution of both proteins (Fig. 7F) matched that of the
ER network in native airway epithelia as recently reported
(22), and their expression was increased in native CF compared
with normal epithelia (Fig. 7, G and H).
These data suggest that chronic airway infection/inflamma-
tion-dependent increases in protein synthesis induce an adap-
tive ER stress response associated with ER expansion and an
increased ER protein folding capacity in CF epithelia in situ. A
consequence of the ER expansion was an increase in calreticu-
lin mRNA (fold increase after SMM treatment  1.4, p  0.05)
and protein levels in the ER (22) that provide increased ER
Ca2 storage, resulting in the amplified Ca2i signals in re-
FIG. 6. Prolonged mucosal exposure of long-term primary cultures of normal bronchial airway epithelia to SMM increases the
syntheses of cytokines and total proteins. A, time course for mucosal PBS- and SMM-dependent IL-8 secretion in normal cultures. B, time
course for mucosal PBS- and SMM-induced IL-1 secretion in normal cultures. C, time course for mucosal PBS- and SMM-dependent IL-6 secretion
in normal cultures. D, total protein synthesis from normal epithelia exposed to mucosal PBS or SMM for 48 h (normalized to [35S]methionine counts
from PBS-treated cultures). Data are from 30–40-day-old primary cultures of normal bronchial epithelia and are expressed as mean  S.E.; n 
3 for all groups. *, p  0.05, SMM- versus PBS-treated cultures.
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sponse to apical GPCR activation that promote amplified IL-8
release, i.e. hyperinflammation.
DISCUSSION
The pathogenesis of CF airway disease is complex. Persistent
intraluminal infection appears to reflect the failure to clear
thickened mucus from the CF lung (47). Airway epithelia play
an active role in the response to the bacterial infection of mucus
by secreting an array of inflammatory mediators and antimi-
crobial factors into the airway lumen (48–50). The ineffective-
ness (and possibly the magnitude of the inflammatory
response) appears to promote airway wall damage and, even-
tually, respiratory failure in CF.
Previous data suggest that inflammation does not precede
infection in CF airways (51, 52). However, the cytokine, e.g.
IL-8, and cellular responses to a defined bacterial load may be
greater in CF than in normal airways, i.e. they are “excessive”
(4, 7, 53). Several reports suggest that one pathway scaling the
magnitude of the cytokine secretion to airways infection is via
Ca2i, and the pathway connecting Ca
2
i responses and cy-
tokine secretion appears to involve activation of transcription
factors such as NF-B. These reports have demonstrated the
following: 1) activation of GPCRs induces NF-B activation and
Ca2i-dependent secretion of inflammatory mediators (11–14);
and 2) infectious agents, or their products, activate NF-B in a
Ca2i mobilization-dependent way (15–17). Recent data sup-
port the view that alterations in airway epithelial Ca2i sig-
naling could, indeed, be implicated in the excessive inflamma-
tory responses of CF airways. These data have revealed that
CF airway epithelia exhibit larger Ca2i responses than nor-
mal epithelia following apical purinoceptor or BK receptor ac-
tivation, which reflect an expansion of the apically confined ER
Ca2 stores (22).
In the present study, we tested the hypothesis that CF air-
way epithelia exhibit excessive inflammatory responses, as
indexed by IL-8 secretion, due to increased Ca2i responses
resulting from ER/Ca2 store expansion. Our findings con-
firmed that primary cultures of CF airway epithelia are hyper-
inflammatory when studied as 6–11-day-old short-term cul-
tures (Fig. 1). However, the CF hyperinflammatory phenotype
is acquired due to chronic luminal infection/inflammation and
is independent of F508 CFTR based on the following obser-
vations: 1) long-term primary cultures of CF airway epithelia
did not exhibit increased baseline or BK-dependent IL-8 secre-
tion when cultured in the absence of luminal infection for
30–40 days (Fig. 1); 2) the IL-8 secretory responses of long-
term primary CF and normal airway epithelial cultures to
SMM exposure were not different (Fig. 2); and 3) a CF-like
hyperinflammatory phenotype, e.g. the amplified BK (or UTP)-
induced IL-8 secretion, could be induced in long-term normal
airway epithelia by exposing their luminal surfaces to SMM
(Figs. 3 and 5). Although it has been controversial whether the
F508 CFTR mutation is directly linked with a hyperinflam-
matory CF airway epithelial response (54), our data suggest
that the hyperinflammatory state of CF airway epithelia rep-
resents an adaptive epithelial response to the chronic infec-
tious/inflammatory milieu found in CF airway lumens in vivo
and is independent of mutant CFTR.
This study revealed that a mechanism of CF airway epithe-
lial hyperinflammation reflects an alteration in ER Ca2i sig-
naling based on the following observations. First, the hyperin-
flammatory state observed in short-term primary cultures of
CF epithelia (Fig. 1) was associated with larger ER-derived
Ca2i mobilization than normal cultures (22). Second, exposure
of normal cultures to SMM potentiated mucosal BK-mobilized
Ca2i as a result of ER Ca
2 store expansion (Fig. 4), repro-
ducing the larger mucosal BK-dependent Ca2i signals from
short-term primary cultures of CF bronchial epithelia (22).
Third, the CF-like hyperinflammation (i.e. increased mucosal
FIG. 7. Airway infection/inflammation induces an ER stress response associated with increases in XBP-1 mRNA splicing and
protein folding ER chaperones in airway epithelia. A, Southern blot illustrating that 48 h mucosal SMM induces IRE1-mediated XBP-1
mRNA splicing in 30–40-day-old cultures of normal bronchial epithelia. B, compiled data for XBP-1 mRNA splicing from PBS- and SMM-treated
cultures (normalized to XBP-1 mRNA splicing from PBS-treated cultures). C, mucosal SMM exposure increases BIP mRNA expression in
30–40-day-old cultures of normal bronchial epithelia (data are normalized to BIP mRNA levels from PBS-treated cultures). D, time course
illustrating BIP expression by immunostaining in 30–40-day-old normal bronchial epithelia exposed to SMM over 48 h. Bar, 10 m. E, compiled
data for BIP apical fluorescence intensity from PBS- or SMM-treated cultures. F, XY confocal scans from normal and CF native human bronchial
epithelia immunostained for BIP and PDI. Bar, 10 m. G and H, percentage of apical fluorescence intensity from BIP and PDI, respectively
(normalized to fluorescence intensity values from normal epithelia). Data are expressed as mean  S.E.; n  3–6 for cultures and n  5 for native
epithelia. *, p  0.05, SMM- versus PBS-treated cultures or CF versus normal epithelia.
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BK-dependent IL-8 secretion resulting from SMM exposure)
was abolished by Ca2i chelation with BAPTA (Figs. 4 and 5).
These data suggest that the larger magnitude of [Ca2]i result-
ing from BK receptor activation in SMM-treated cultures
reached the critical threshold for Ca2i-dependent activation of
IL-8 transcription. The delay between the GPCR-triggered
Ca2i and onset of IL-8 protein secretion reflects the kinetics
of activation of Ca2i-dependent transcription (55) and protein
translation. Based on previous studies, we speculate that fol-
lowing BK-induced [Ca2]i elevation, NF-B is freed from IB
inhibition and translocates to the nucleus, where it can reside
for tens of minutes, resulting in persistent transcriptional ac-
tivation (55), despite the relaxation of Ca2i levels toward
baseline levels (Fig. 4) (22).
The proposed role of amplified ER-derived Ca2i responses in
CF pathogenesis in the present study is in agreement with
previous findings of increases in ER Ca2 stores in the patho-
genesis of Gaucher disease (23) and Alzheimer disease (24, 25),
although different mechanisms may participate in the genesis
of ER expansion in these diseases. In the case of CF, we spec-
ulate that an airway epithelial adaptation to chronic luminal
stimulation by bacterial/host products is the increased synthe-
sis and secretion of cytokines and antimicrobial proteins (Fig.
6). The increased protein synthesis requires an increased ER
protein folding capacity, triggering an ER response that is
characterized by increased XBP-1 mRNA splicing (Fig. 7, A and
B), increased expression of ER chaperones (Fig. 7, CH), and
expansion of the ER compartment and its Ca2 stores (Fig. 4)
(22). A model for describing the linkage between increased
protein synthesis and ER expansion has been the B lymphocyte
and plasma cell differentiation path. The high rate of immuno-
globulin secretion by plasma cells requires ER expansion (39),
and this process depends on XBP-1 mRNA splicing (56). The
link among chronic airway epithelial infection/inflammation,
ER expansion, and an increase in ER Ca2 stores was recently
reported in studies that demonstrated SMM-induced increases
in the ER mass and the ER Ca2 store marker calreticulin (22).
Of note, ER expansion has been previously described in re-
sponse to other forms of bacterial infection (57).
ER expansion likely impacts on the adaptation by airway
epithelia to intraluminal infection in multiple ways. First, it
provides a key cellular adaptation to mediate the increased
protein synthesis required for infection-stimulated increases in
secretion of host defense factors and cellular repair. Second, it
may amplify the inflammatory response to persistent airway
infection. For example, airway epithelia exposed to intralumi-
FIG. 8. Proposed model linking the hyperinflammatory response of CF airway epithelia to ER Ca2 store expansion induced by
persistent luminal infection/inflammation. Illustration of the sequence of events that leads to the Ca2i-dependent CF hyperinflammatory
phenotype. The initiating stimulus is persistent intraluminal airways infection (B). A response to this infection, the increased epithelial synthesis
and secretion of antimicrobial factors and cytokines (B), triggers ER expansion and increased ER Ca2 stores (C). The consequent increase in the
magnitude of Ca2i signals mediates a component of CF airway hyper-responsiveness, i.e. it primes the airways to secrete cytokines via a
Ca2i-dependent pathway in response to luminal infectious/inflammatory stimuli (C). In CF, elements of this amplified response are protective, e.g.
nucleotide-induced Ca2i-enhanced mucociliary clearance (22), whereas other elements may be maladaptive, e.g. the increased Ca
2
i-dependent
IL-8 secretion recruits inflammatory cells that are ineffective in thick mucus and paradoxically injure airway walls by proteolytic enzyme release.
Thus, the increased ER-dependent, Ca2i-mediated hyperinflammatory epithelial response is responsible, at least in part, for the acquisition of the
amplified CF airways inflammation.
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nal bacterial infection for prolonged periods (	24 h) become
primed via greater ER Ca2 stores to secrete higher levels of
cytokines as a result of increased Ca2i mobilization in re-
sponse to stimuli that signal through Ca2i such as BK (Figs.
1, 4, and 5) (22). We speculate that under normal circum-
stances, the amplification of the inflammatory response conse-
quent to expansion of ER/Ca2 stores is beneficial. For exam-
ple, the increased inflammatory mediator-dependent IL-8
secretion that may occur 24–48 h after initiation of infection
would result in progressive recruitment of inflammatory cells
to rid the lumen of infection (Figs. 3 and 5). In CF, however,
amplified cytokine responses following chronic bacterial infec-
tion may be maladaptive because the bacteria are protected in
the thickened mucus environment in CF airways, and inflam-
matory cells cannot eradicate these bacteria (47). Thus, the
persistent but ineffective “amplified” inflammatory cascade in
CF may have an adverse impact on the host, i.e. destruction of
the airway wall, rather than the bacterial target.
A summary of the sequence of events that leads to the CF
hyperinflammatory phenotype is depicted in Fig. 8. The initi-
ating stimulus is persistent intraluminal airway infection (Fig.
8B). A response to this infection, the increased epithelial syn-
thesis and secretion of antimicrobial factors and cytokines (Fig.
8B), triggers ER expansion and increased ER Ca2 stores (Fig.
8C). The consequent increase in the magnitude of Ca2i signals
mediates a component of CF airway “hyper-responsiveness”,
i.e. it primes the epithelial cells to secrete cytokines via a
Ca2i-dependent pathway in response to luminal infectious/
inflammatory stimuli (Fig. 8C). In CF, elements of this ampli-
fied response are protective, e.g. Ca2i-enhanced mucociliary
clearance (22), whereas other elements may be maladaptive,
e.g. the increased Ca2i-dependent IL-8 secretion recruits in-
flammatory cells that are ineffective in thick mucus and para-
doxically injure airway walls by proteolytic enzyme release.
Thus, the most effective way to treat the inflammation-induced
damage to airway walls is to remove the persistent stimulus,
i.e. infected mucus plaques/plugs, from CF airway surfaces.
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